Santoro Nanette
Division of Reproductive Endocrinology, Albert Einstein College of Medicine, Bronx, New York 10461, USA.
Clin Obstet Gynecol. 2008 Sep;51(3):539-48. doi: 10.1097/GRF.0b013e31818093f6.
Vasomotor symptoms (VMSs) are highly prevalent during the peri- and early postmenopause. They constitute a major driver for patient self-referral for medical care. Although most women will experience an abatement of their VMS by 5 years after their final menses, women with early or surgical menopause may have worse or more persistent symptoms, and up to 16% of naturally menopausal women continue to experience VMS well after their menopause is past. Although estrogen is the most effective known therapy, it is neither appropriate nor desirable for every symptomatic woman, and nonhormonal treatments such as gabapentin, selective serotonin reuptake inhibitors/selective norepinephrine reuptake inhibitors drugs, and the antihypertensives clonidine and alphamethyldopa may be helpful for some women. There is mounting evidence to support the ineffectiveness of many proposed complementary and alternative modalities. This review will highlight the natural history of VMS and the current medical evidence supporting various treatments.
血管舒缩症状(VMS)在围绝经期和绝经早期极为普遍。它们是患者自行寻求医疗护理的主要驱动因素。尽管大多数女性在末次月经后5年内VMS会减轻,但早发性或手术绝经的女性可能症状更严重或持续时间更长,高达16%的自然绝经女性在绝经后很长时间仍会持续出现VMS。尽管雌激素是已知最有效的治疗方法,但并非对每个有症状的女性都合适或可取,加巴喷丁、选择性5-羟色胺再摄取抑制剂/选择性去甲肾上腺素再摄取抑制剂药物以及抗高血压药可乐定和甲基多巴等非激素治疗方法可能对某些女性有帮助。越来越多的证据表明许多提议的补充和替代疗法无效。本综述将重点介绍VMS的自然病史以及支持各种治疗方法的当前医学证据。